Mini Review

Published on 21 Feb 2022

Current Use and Complementary Value of Combining in Vivo Imaging Modalities to Understand the Renoprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors at a Tissue Level

in Renal Pharmacology

Sjoukje van der Hoek
Jasper Stevens

Frontiers in Pharmacology

doi 10.3389/fphar.2022.837993

1,826 views
2 citations

Review

Published on 14 Feb 2022

Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease

in Renal Pharmacology

Colleen S. Curran
Jeffrey B. Kopp

Frontiers in Pharmacology

doi 10.3389/fphar.2022.782199

6,946 views
19 citations

Original Research

Published on 11 Feb 2022

Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression

in Renal Pharmacology

Jiayi Xiang
Huifang Zhang
Xingcheng Zhou
Dan Wang
Rongyu Chen
Wanlin Tan
Luqun Liang
Mingjun Shi
Fan Zhang
Ying Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.819787

4,205 views
11 citations

Systematic Review

Published on 11 Feb 2022

Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis

in Renal Pharmacology

Chia-Hsien Chen
Wei-Cheng Lo
Ping‐Jen Hu
Hsiu-Chen Chan
Wan-Chen Shen
Mai-Szu Wu
Mei-Yi Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.822178

18,588 views
14 citations

Original Research

Published on 10 Feb 2022

Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway

in Renal Pharmacology

Linzi Long
Xiuli Zhang
Ying Wen
Jiapeng Li
Lihui Wei
Ying Cheng
Huixin Liu
Jianfeng Chu
Yi Fang
Qiurong Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2021.770863

2,753 views
13 citations

Original Research

Published on 10 Feb 2022

Cordyceps cicadae Ameliorates Renal Hypertensive Injury and Fibrosis Through the Regulation of SIRT1-Mediated Autophagy

in Renal Pharmacology

Yuzi Cai
Zhendong Feng
Qi Jia
Jing Guo
Pingna Zhang
Qihan Zhao
Yao Xian Wang
Yu Ning Liu
Wei Jing Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.801094

5,554 views
21 citations

Review

Published on 10 Feb 2022

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease

in Renal Pharmacology

Yinghui Wang
Lu Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.800950

8,058 views
43 citations

Original Research

Published on 07 Feb 2022

Combining Neprilysin Inhibitor With AT2R Agonist Is Superior to Combination With AT1R Blocker in Providing Reno-Protection in Obese Rats

in Renal Pharmacology

Elizabeth Alana Gray
Sanket N. Patel
Peter A. Doris
Tahir Hussain

Frontiers in Pharmacology

doi 10.3389/fphar.2021.778953

2,821 views
1 citation

Systematic Review

Published on 07 Feb 2022

Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

in Renal Pharmacology

Ming-Zhu Zhang
Wujisiguleng Bao
Qi-Yan Zheng
Ya-Hui Wang
Lu-Ying Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2022.819327

12,365 views
20 citations

Original Research

Published on 04 Feb 2022

Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19

in Renal Pharmacology

Kai Kang
Yunpeng Luo
Yang Gao
Jiannan Zhang
Changsong Wang
Dongsheng Fei
Wei Yang
Xianglin Meng
Ming Ye
Yan Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2022.817793

7,354 views
19 citations

Original Research

Published on 31 Jan 2022

SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease

in Renal Pharmacology

Qianqian Yang
Wenjia Xie
Xiao Wang
Jing Luo
Yang Zhou
Hongdi Cao
Qi Sun
Lei Jiang
Junwei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.707006

3,034 views
5 citations

Original Research

Published on 28 Jan 2022

Ketamine Induced Bladder Fibrosis Through MTDH/P38 MAPK/EMT Pathway

in Renal Pharmacology

Quan Zhu
Kaixuan Li
Haozhen Li
Feng Han
Zhengyan Tang
Zhao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.743682

4,280 views
5 citations

Original Research

Published on 28 Jan 2022

The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

in Renal Pharmacology

Ming-Hsien Tsai
Mingchih Chen
Yen-Chun Huang
Hung-Hsiang Liou
Yu-Wei Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.804000

2,249 views
3 citations

Original Research

Published on 27 Jan 2022

Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways

in Renal Pharmacology

Qian Ren
Bo Wang
Fan Guo
Rongshuang Huang
Zhouke Tan
Liang Ma
Ping Fu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.792139

4,651 views
17 citations

Original Research

Published on 25 Jan 2022

Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones

in Renal Pharmacology

Laura Szalai
András Sziráki
László Sándor Erdélyi
Kinga Bernadett Kovács
Miklós Tóth
András Dávid Tóth
Gábor Turu
Dominique Bonnet
Bernard Mouillac
László Hunyady

Frontiers in Pharmacology

doi 10.3389/fphar.2022.811836

5,871 views
9 citations

Review

Published on 25 Jan 2022

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis

in Renal Pharmacology

Jun Li
Xuezhong Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.820071

4,791 views
16 citations

Navigation group

Articles

Current Use and Complementary Value of Combining in Vivo Imaging Modalities to Understand the Renoprotective Effects of Sodium-Glucose Cotransporter-2 Inhibitors at a Tissue Level

Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease

Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression

Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis

Qingda Granule Attenuates Angiotensin II-Induced Renal Apoptosis and Activation of the p53 Pathway

Cordyceps cicadae Ameliorates Renal Hypertensive Injury and Fibrosis Through the Regulation of SIRT1-Mediated Autophagy

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease

Combining Neprilysin Inhibitor With AT2R Agonist Is Superior to Combination With AT1R Blocker in Providing Reno-Protection in Obese Rats

Efficacy and Safety of Finerenone in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Continuous Renal Replacement Therapy With oXiris Filter May Not be an Effective Resolution to Alleviate Cytokine Release Syndrome in Non-AKI Patients With Severe and Critical COVID-19

SS31 Ameliorates Podocyte Injury via Inhibiting OMA1-Mediated Hydrolysis of OPA1 in Diabetic Kidney Disease

Ketamine Induced Bladder Fibrosis Through MTDH/P38 MAPK/EMT Pathway

The Protective Effects of Lipid-Lowering Agents on Cardiovascular Disease and Mortality in Maintenance Dialysis Patients: Propensity Score Analysis of a Population-Based Cohort Study

Natural Flavonoid Pectolinarigenin Alleviated Hyperuricemic Nephropathy via Suppressing TGFβ/SMAD3 and JAK2/STAT3 Signaling Pathways

Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis